Analysis

From food to pharma: antioxidant scavengers as a viable strategy to mitigate nitrosamines in drugs

Stakeholders throughout the pharmaceutical value chain have had to deal with the recall of nitrosamine-containing medications, loss of revenue and, in some cases, reputational damage. Meanwhile, regulatory authorities have put stringent measures in motion to protect patients from potentially harmful medications, putting reformulation at the forefront of drug manufacturers’ minds, reports Anne-Cecile Bayne, Global Science and Innovation Lead, Pharma and Medical Nutrition at DSM

Breaking News

Clean Cells launches activities at biopharmaceutical facility

With 5,300 sqm of new premises, €22 million building offers four times more laboratory space than previous facility

Get ahead of the curve in 2023 with a subscription

Keep abreast of significant pharmaceutical developments around the world

PeakData raises $12.1m to connect pharma companies to healthcare professionals

The funds have been raised to grow the company's AI platform that identifies and collates the most relevant and impactful healthcare professionals...

Pharma turns to CD8 in vivo imaging to predict response to immunotherapy

Improving the success rates of immunotherapy drugs has long been a difficult challenge. But finding ways to accurately measure the presence of CD8+...

Titan Enterprises expands its liquid flowmeter calibration capacity

Titan Enterprises has been performing all its calibration requirements in-house since 1994 using their positive displacement oil or water flow rigs...

Medicines Discovery Catapult and ZEISS set sights on advancing microscopy in drug discovery

Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing...

Maximising data quality in digital PCR

Data forms the backbone of all scientific innovation, guiding researchers in their experimental direction and contributing to meaningful conclusion...

From food to pharma: antioxidant scavengers as a viable strategy to mitigate nitrosamines in drugs

Stakeholders throughout the pharmaceutical value chain have had to deal with the recall of nitrosamine-containing medications, loss of revenue and,...

The new Nebula Multimode Reader from Lonza streamlines quantitative endotoxin detection

A single reader minimises space requirements, training burden and maintenance contracts for endotoxin detection

Thermo Fisher Scientific showcases new clinical and research lab solutions at AACC 2022

The advanced tools and technologies enable improved flexibility and productivity for diagnostics development and support advanced allergy and autoi...

Detection and global data: a revolutionary tool in the fight against counterfeit pharmaceuticals

The detection of counterfeit pharmaceutical goods is hindered by lengthy waits for results and a reliance on centralised testing. These bottlenecks...

Host cell protein analysis: strategies to improve sensitivity and reproducibility

Given that the US FDA approved 25 new cellular and gene therapy products in 2022, gene-based vaccines and therapeutics have now entered the mainstr...

Vector Laboratories launches Glysite Scout Glycan Screening Kits to progress glycobiology research

Offers a new, promising frontier to advance research and exploration of diseased and healthy tissue

Metabolomics research group brings power of TIMS to bear on understanding human health and disease

How utilising trapped ion mobility spectrometry (TIMS) has enhanced the use of mass spectrometry (MS) for accurate metabolite analysis at the Novo...

Eluceda develops novel hydrogen peroxide test

Chemical and biological detection technology specialist, Eluceda has developed and launched a rapid, quantitative and portable test for hydrogen pe...